Skip to main content
Clinical Trials/NCT05796518
NCT05796518CompletedNot Applicable

A Pilot Study to Examine Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Wake Forest University Health Sciences2 sites in 1 country44 target enrollmentStarted: September 7, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
44
Locations
2
Primary Endpoint
Number of Participants to Complete Intervention - Feasibility

Study Overview

Brief Summary

Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.

Detailed Description

Primary Objective: The primary objective of this pilot study is to assess the feasibility of enrolling and completing the heart health assessment among endometrial cancer patients scheduled for routine follow-up care.

Secondary Objectives:

  • To assess patient satisfaction with the tool.
  • To identify the proportion of patients with non-ideal cardiovascular health scores who report initiating discussions regarding cardiovascular health during their routine oncology appointment.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
  • Greater than or equal to 3 months post-potentially curative cancer treatment
  • Patients must be at least 18 years of age
  • Have a working email address
  • Comfortable reading medical information in English, as per self-report

Exclusion Criteria

  • Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
  • Have a history of endometrial cancer recurrence
  • Enrolled in hospice care or documentation of life expectancy < 6 months

Outcomes

Primary Outcomes

Number of Participants to Complete Intervention - Feasibility

Time Frame: 6 months

Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.

Secondary Outcomes

  • Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health With Health Care Providers(6 months)
  • Number of Participants Stating Satisfaction With PREVENT Tool(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Feasibility of a Patient Directed Tool to... | Clinical Trial